Stocks News
Coherus Oncology Q4 Loss Widens: CHRS Stock Analysis and 2026 Outlook
REDWOOD CITY, Calif. — March 9, 2026: Biotechnology firm Coherus BioSciences, Inc. (NASDAQ: CHRS) reported a wider-than-expected fourth-quarter loss after markets closed...
